Panagiotopoulos S - Search Results

1

Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function.

Ekinci EI, Jerums G, Skene A, Crammer P, Power D, Cheong KY, Panagiotopoulos S, McNeil K, Baker ST, Fioretto P, Macisaac RJ. Ekinci EI, et al. Among authors: panagiotopoulos s. Diabetes Care. 2013 Nov;36(11):3620-6. doi: 10.2337/dc12-2572. Epub 2013 Jul 8. Diabetes Care. 2013. PMID: 23835690 Free PMC article.

2

The effects of dietary cholesterol on experimental diabetic nephropathy.

Cooper ME, Vranes D, Vranes DA, Allen TJ, Panagiotopoulos S, Komers R, Jerums G. Cooper ME, et al. Among authors: panagiotopoulos s. Diabetes Res. 1993;22(4):159-69. Diabetes Res. 1993. PMID: 8070237

3

Progressive decline in renal function in diabetic patients with and without albuminuria.

Tsalamandris C, Allen TJ, Gilbert RE, Sinha A, Panagiotopoulos S, Cooper ME, Jerums G. Tsalamandris C, et al. Among authors: panagiotopoulos s. Diabetes. 1994 May;43(5):649-55. doi: 10.2337/diab.43.5.649. Diabetes. 1994. PMID: 8168641

4

Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate.

Panagiotopoulos S, Smith TJ, Aldred GP, Baker EJ, Jacklin CJ, Jerums G. Panagiotopoulos S, et al. J Diabetes Complications. 1995 Oct-Dec;9(4):272-6. doi: 10.1016/1056-8727(95)80020-f. J Diabetes Complications. 1995. PMID: 8573745

5

Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.

Gin T, Joon TL, Panagiotopoulos S, Cooper M, Taylor H, Jerums G. Gin T, et al. Among authors: panagiotopoulos s. Invest Ophthalmol Vis Sci. 1996 Feb;37(2):281-9. Invest Ophthalmol Vis Sci. 1996. PMID: 8603832

6

Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.

Soulis T, Cooper ME, Sastra S, Thallas V, Panagiotopoulos S, Bjerrum OJ, Jerums G. Soulis T, et al. Among authors: panagiotopoulos s. Diabetologia. 1997 Oct;40(10):1141-51. doi: 10.1007/s001250050799. Diabetologia. 1997. PMID: 9349594

7

Why is proteinuria such an important risk factor for progression in clinical trials?

Jerums G, Panagiotopoulos S, Tsalamandris C, Allen TJ, Gilbert RE, Comper WD. Jerums G, et al. Among authors: panagiotopoulos s. Kidney Int Suppl. 1997 Dec;63:S87-92. Kidney Int Suppl. 1997. PMID: 9407431 Review.

8

Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit.

Panagiotopoulos S, O'Brien RC, Bucala R, Cooper ME, Jerums G. Panagiotopoulos S, et al. Atherosclerosis. 1998 Jan;136(1):125-31. doi: 10.1016/s0021-9150(97)00192-5. Atherosclerosis. 1998. PMID: 9544739

9

Long-term intraindividual variability of serum lipids in patients with type I and type II diabetes.

Tsalamandris C, Panagiotopoulos S, Allen TJ, Waldrip L, Van Gaal B, Goodall I, Jerums G. Tsalamandris C, et al. Among authors: panagiotopoulos s. J Diabetes Complications. 1998 Jul-Aug;12(4):208-14. doi: 10.1016/s1056-8727(97)00122-0. J Diabetes Complications. 1998. PMID: 9647339

10

Alterations in renal degradation of albumin in early experimental diabetes in the rat: a new factor in the mechanism of albuminuria.

Burne MJ, Panagiotopoulos S, Jerums G, Comper WD. Burne MJ, et al. Among authors: panagiotopoulos s. Clin Sci (Lond). 1998 Jul;95(1):67-72. Clin Sci (Lond). 1998. PMID: 9662487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters